Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

INTRODUCTION: Circulating tumor cells (CTCs) represent an independent predictor of outcome in patients with metastatic breast cancer (MBC). We assessed the prognostic impact of CTCs according to different first-line systemic treatments, and explored their potential predictive value in MBC patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Giuliano, Mario, Giordano, Antonio, Jackson, Summer, Hess, Kenneth R, De Giorgi, Ugo, Mego, Michal, Handy, Beverly C, Ueno, Naoto T, Alvarez, Ricardo H, De Laurentiis, Michelino, De Placido, Sabino, Valero, Vicente, Hortobagyi, Gabriel N, Reuben, James M, Cristofanilli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218956/
https://www.ncbi.nlm.nih.gov/pubmed/21699723
http://dx.doi.org/10.1186/bcr2907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218956/
https://www.ncbi.nlm.nih.gov/pubmed/21699723
http://dx.doi.org/10.1186/bcr2907

Ejemplares similares